Indian Journal of Nuclear Medicine

REVIEW ARTICLE
Year
: 2014  |  Volume : 29  |  Issue : 1  |  Page : 2--12

PET/CT imaging of neuroendocrine tumors with 68Gallium-labeled somatostatin analogues: An overview and single institutional experience from India


Punit Sharma, Harmandeep Singh, Chandrasekhar Bal, Rakesh Kumar 
 Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India

Correspondence Address:
Rakesh Kumar
E-81, Ansari Nagar (East), All India Institute of Medical Sciences Campus, New Delhi - 110 029
India

Neuroendocrine tumors (NETs) are rare neoplasms characterized by overexpression of somatostatin receptors (SSTRs). Functional imaging plays a crucial role in management of NETs. Recently, positron emission tomography/computed tomography (PET/CT) with 68Gallium (68Ga)-labeled somatostatin analogues has shown excellent results for imaging of NETs and better results than conventional SSTR scintigraphy. In this review we have discussed the utility of 68 Ga-labeled somatostatin analogue PET/CT in NETs for various established and potential indications. In addition we have also shared our own experience from a tertiary care center in India.


How to cite this article:
Sharma P, Singh H, Bal C, Kumar R. PET/CT imaging of neuroendocrine tumors with 68Gallium-labeled somatostatin analogues: An overview and single institutional experience from India.Indian J Nucl Med 2014;29:2-12


How to cite this URL:
Sharma P, Singh H, Bal C, Kumar R. PET/CT imaging of neuroendocrine tumors with 68Gallium-labeled somatostatin analogues: An overview and single institutional experience from India. Indian J Nucl Med [serial online] 2014 [cited 2019 Oct 22 ];29:2-12
Available from: http://www.ijnm.in/article.asp?issn=0972-3919;year=2014;volume=29;issue=1;spage=2;epage=12;aulast=Sharma;type=0